Pages that link to "Q37798009"
Jump to navigation
Jump to search
The following pages link to Experimental rabies vaccines for humans (Q37798009):
Displaying 26 items.
- Investigating the role for IL-21 in rabies virus vaccine-induced immunity (Q34630598) (← links)
- Comparison of safety and immunogenicity of PVRV and PCECV immunized in patients with WHO category II animal exposure: a study based on different age groups. (Q34733982) (← links)
- Lymph node but not intradermal injection site macrophages are critical for germinal center formation and antibody responses to rabies vaccination (Q35076738) (← links)
- Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine (Q35184639) (← links)
- Canine Rabies: A Looming Threat to Public Health (Q35884876) (← links)
- Louis pasteur, the father of immunology? (Q35927551) (← links)
- Translational research in infectious disease: current paradigms and challenges ahead (Q35992621) (← links)
- Protective vaccine-induced CD4(+) T cell-independent B cell responses against rabies infection (Q36363223) (← links)
- B cell infection and activation by rabies virus-based vaccines (Q37123384) (← links)
- Reinvestigating the role of IgM in rabies virus postexposure vaccination (Q37123389) (← links)
- Wild-type rabies virus induces autophagy in human and mouse neuroblastoma cell lines. (Q37365445) (← links)
- ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo (Q37529574) (← links)
- Rabies virus as a research tool and viral vaccine vector (Q37877958) (← links)
- Functional nanomaterials can optimize the efficacy of vaccines (Q38252639) (← links)
- Rabies vaccines: where do we stand, where are we heading? (Q38263028) (← links)
- Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment (Q39080297) (← links)
- Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans (Q39084014) (← links)
- Multivariate analysis of the immune response to a vaccine as an alternative to the repetition of animal challenge studies for vaccines with demonstrated efficacy (Q40137921) (← links)
- APRIL:TACI axis is dispensable for the immune response to rabies vaccination (Q40158110) (← links)
- Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis (Q40355293) (← links)
- A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge (Q40824269) (← links)
- Establishing Correlates of Protection for Vaccine Development: Considerations for the Respiratory Syncytial Virus Vaccine Field (Q47553316) (← links)
- Rabies-based vaccine induces potent immune responses against Nipah virus (Q64114537) (← links)
- A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model (Q64360537) (← links)
- Advances in rabies prophylaxis and treatment with emphasis on immunoresponse mechanisms (Q91744323) (← links)
- A chimpanzee adenoviral vector-based rabies vaccine protects beagle dogs from lethal rabies virus challenge (Q92501288) (← links)